The page is the record's research on the issuer — no analyst, no rating, no view.

Modus Therapeutics Holding AB (SE0015987904) — research page

SE · se-cm-kg/SSME/SE0015987904 · as of 2026-11-06

Identity and listing

The issuer is Modus Therapeutics Holding AB, listed on First North Sweden under ticker SE0015987904. Its ISIN is SE0015987904 and its LEI is 984500C147FB4EF4A471. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.

fieldvaluesource · read date
nameModus Therapeutics Holding ABsource · 2026-11-06
exchangeFirst North Swedensource · 2026-11-06
tickerSE0015987904source · 2026-11-06
ISINSE0015987904source · 2026-11-06
LEI984500C147FB4EF4A471source · 2026-11-09
security typenot on the record
segmentnot on the record
sectornot on the record
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 21 filings across 19 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 10.0 days, and the median for First North Sweden is 11.0 days across 325 issuers. The median latency from the latest filing to the record date is 16 days, against a median of 7 days for the exchange. The sector median is not on the record. The latest filing is an Investor News item dated 2026-10-21. The filings comprise one Annual financial report, nine Company Announcements, one Decisions of general meeting, one Financial statement release, one Half year financial report, two Interim reports (Q1 and Q3), five Investor News items and one Notice to general meeting.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer211016
exchange median: First North Sweden (325 issuers)21117
datetypecategoryfiling
2026-10-21Investor NewsInvestor NewsModus Therapeutics: SEVUSMART study of sevuparin in children with severe malaria published in Nature Communications
2026-10-14Company AnnouncementCompany AnnouncementModus Therapeutics temporarily pauses enrollment in Phase IIa study of sevuparin in CKD with anemia
2026-09-29Company AnnouncementCompany AnnouncementModus announces outcome of the first exercise period for warrants of series TO 2030; receives approximately SEK 134 thousand
2026-09-11Company AnnouncementCompany AnnouncementThe first exercise period for Modus Therapeutics' warrants of series TO 2030 commences on 14 September 2026
2026-09-03Company AnnouncementCompany AnnouncementModus Therapeutics carries out a directed issue of SEK 7.6 million

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record, and its location is not on the record. The market's record does not carry auditor changes for this register.

Events and halts

The record does not carry listing, delisting, name change, domicile change or segment move events, because no lifecycle type map exists for this register yet. The halt flag is listed, not halted.

Orderability

The outcome is not determinable under the rule version acm-68000/se/mifid-ii-product-governance/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.

rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations page as read.

Open research

No openly published research notes were found on the record.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. No sealed years hold the issuer. The live record began on a date not on the record.

Sources

6 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://firds.esma.europa.eu/firds/ (identity.exchange)
10.2
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.3
https://mcp.se-cm-kg.ai/events/SSME/SE0015987904 (the disclosure lines)
10.4
https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
10.5
https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
10.6
https://mcp.se-cm-kg.ai/record/SSME/SE0015987904 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0015987904"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:33852ac135b89df2.